CV19 Lab Testing Dashboard powered by hc1
To support health care providers and public health agencies in responding to the COVID-19 pandemic,
hc1 is leading a coalition of 20K+ lab testing locations to power the CV19 Lab Testing Dashboard.


FDA Directs New Opioid Labeling

August 26, 2019 In April 2019, the Food and Drug Administration (FDA) issued a safety communication requiring opioid labeling changes to guide prescribers and patients on gradual, individualized tapering. The change was made after reports of serious harm in patients physically dependent on opioid pain medicines suddenly having the medicines discontinued or the dose rapidly decreased. Discontinuing or rapidly decreasing dose in dependent patients can cause serious withdrawal symptoms, uncontrolled pain, psychological distress and suicide.…
Subscribe to the blog